Logo image of AVTE

AEROVATE THERAPEUTICS INC (AVTE) Stock Price, Quote, News and Overview

NASDAQ:AVTE - Nasdaq - US0080641071 - Common Stock - Currency: USD

2.68  0 (0%)

After market: 2.6505 -0.03 (-1.1%)

AVTE Quote, Performance and Key Statistics

AEROVATE THERAPEUTICS INC

NASDAQ:AVTE (4/28/2025, 8:00:00 PM)

After market: 2.6505 -0.03 (-1.1%)

2.68

0 (0%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High25.29
52 Week Low1.25
Market Cap77.69M
Shares28.99M
Float28.96M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-12 2025-05-12/amc
IPO06-30 2021-06-30


AVTE short term performance overview.The bars show the price performance of AVTE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 4

AVTE long term performance overview.The bars show the price performance of AVTE in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of AVTE is 2.68 USD. In the past month the price increased by 5.93%. In the past year, price decreased by -86.79%.

AEROVATE THERAPEUTICS INC / AVTE Daily stock chart

AVTE Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19 345.13B
AMGN AMGEN INC 14.68 156.41B
GILD GILEAD SCIENCES INC 13.76 132.82B
VRTX VERTEX PHARMACEUTICALS INC 1756.9 130.98B
REGN REGENERON PHARMACEUTICALS 13.51 65.46B
ARGX ARGENX SE - ADR 339.55 39.39B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 34.24B
ONC BEIGENE LTD-ADR N/A 28.00B
BNTX BIONTECH SE-ADR N/A 25.04B
NTRA NATERA INC N/A 20.40B
SMMT SUMMIT THERAPEUTICS INC N/A 17.79B
BIIB BIOGEN INC 7.35 17.72B

About AVTE

Company Profile

AVTE logo image Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. The company is headquartered in Waltham, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2021-06-30. The firm is in the process of exploring strategic alternatives, which may include, but are not limited to, an acquisition, merger, reverse merger, business combination, liquidation or other transaction.

Company Info

AEROVATE THERAPEUTICS INC

930 Winter Street, Suite M-500

Waltham MASSACHUSETTS US

CEO: Timothy P. Noyes

Employees: 51

Company Website: https://www.aerovatetx.com/

Investor Relations: https://ir.aerovatetx.com/

Phone: 16174432400

AEROVATE THERAPEUTICS INC / AVTE FAQ

What is the stock price of AEROVATE THERAPEUTICS INC today?

The current stock price of AVTE is 2.68 USD.


What is the ticker symbol for AEROVATE THERAPEUTICS INC stock?

The exchange symbol of AEROVATE THERAPEUTICS INC is AVTE and it is listed on the Nasdaq exchange.


On which exchange is AVTE stock listed?

AVTE stock is listed on the Nasdaq exchange.


What is AEROVATE THERAPEUTICS INC worth?

AEROVATE THERAPEUTICS INC (AVTE) has a market capitalization of 77.69M USD. This makes AVTE a Micro Cap stock.


How many employees does AEROVATE THERAPEUTICS INC have?

AEROVATE THERAPEUTICS INC (AVTE) currently has 51 employees.


What are the support and resistance levels for AEROVATE THERAPEUTICS INC (AVTE) stock?

AEROVATE THERAPEUTICS INC (AVTE) has a support level at 2.62 and a resistance level at 2.72. Check the full technical report for a detailed analysis of AVTE support and resistance levels.


Should I buy AEROVATE THERAPEUTICS INC (AVTE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AEROVATE THERAPEUTICS INC (AVTE) stock pay dividends?

AVTE does not pay a dividend.


When does AEROVATE THERAPEUTICS INC (AVTE) report earnings?

AEROVATE THERAPEUTICS INC (AVTE) will report earnings on 2025-05-12, after the market close.


What is the Price/Earnings (PE) ratio of AEROVATE THERAPEUTICS INC (AVTE)?

AEROVATE THERAPEUTICS INC (AVTE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.44).


AVTE Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to AVTE. When comparing the yearly performance of all stocks, AVTE is a bad performer in the overall market: 90.58% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

AVTE Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to AVTE. No worries on liquidiy or solvency for AVTE as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AVTE Financial Highlights

Over the last trailing twelve months AVTE reported a non-GAAP Earnings per Share(EPS) of -2.44. The EPS increased by 15.28% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -86.68%
ROE -91.1%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%74.32%
Sales Q2Q%N/A
EPS 1Y (TTM)15.28%
Revenue 1Y (TTM)N/A

AVTE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 49% to AVTE. The Buy consensus is the average rating of analysts ratings from 9 analysts.


Ownership
Inst Owners106.64%
Ins Owners0.08%
Short Float %N/A
Short Ratio15
Analysts
Analysts48.89
Price TargetN/A
EPS Next Y74.29%
Revenue Next YearN/A